PROMETHAZINE DM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Promethazine Dm, and when can generic versions of Promethazine Dm launch?
Promethazine Dm is a drug marketed by Slate Run Pharma and is included in one NDA.
The generic ingredient in PROMETHAZINE DM is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
Summary for PROMETHAZINE DM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 7 |
Clinical Trials: | 58 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PROMETHAZINE DM |
DailyMed Link: | PROMETHAZINE DM at DailyMed |
Recent Clinical Trials for PROMETHAZINE DM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Trauma Center | N/A |
Oman Medical Speciality Board | Phase 3 |
Tanta University | N/A |
Pharmacology for PROMETHAZINE DM
Anatomical Therapeutic Chemical (ATC) Classes for PROMETHAZINE DM
US Patents and Regulatory Information for PROMETHAZINE DM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Slate Run Pharma | PROMETHAZINE DM | dextromethorphan hydrobromide; promethazine hydrochloride | SYRUP;ORAL | 040649-001 | Feb 14, 2006 | AA | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |